{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:12:03Z","timestamp":1791223923645,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.schres.2011.04.028","type":"journal-article","created":{"date-parts":[[2011,5,21]],"date-time":"2011-05-21T12:46:42Z","timestamp":1305982002000},"page":"127-132","source":"Crossref","is-referenced-by-count":51,"title":["Time to discontinuation of first- and second-generation antipsychotic medications in the treatment of schizophrenia"],"prefix":"10.1016","volume":"131","author":[{"given":"Julie","family":"Kreyenbuhl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P.","family":"Slade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah R.","family":"Medoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton H.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ehrenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Afful","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa B.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2011.04.028_bb0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-244X-6-8","article-title":"Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia","volume":"6","author":"Ascher-Svanum","year":"2006","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2011.04.028_bb0010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.psc.2007.04.002","article-title":"Antipsychotic medication adherence in schizophrenia","volume":"30","author":"Byerly","year":"2007","journal-title":"Psychiatr. Clin. North Am."},{"issue":"14","key":"10.1016\/j.schres.2011.04.028_bb0015","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/070674370505001404","article-title":"Ambulatory use of olanzapine and risperidone: a population-based study on persistence and the use of concomitant therapy in the treatment of schizophrenia","volume":"50","author":"Cooper","year":"2005","journal-title":"Can. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2011.04.028_bb0115","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4088\/JCP.v68n0601","article-title":"Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia","volume":"68","author":"Cooper","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2011.04.028_bb0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J. Roy. Stat. Soc."},{"issue":"4","key":"10.1016\/j.schres.2011.04.028_bb0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/A:1011137630558","article-title":"Cross-system service use among VA mental health patients living in Philadelphia","volume":"28","author":"Desai","year":"2001","journal-title":"Adm. Policy Ment. Health"},{"issue":"1","key":"10.1016\/j.schres.2011.04.028_bb0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF02287807","article-title":"Cross-system service use among psychiatric patients: data from the Department of Veterans Affairs","volume":"27","author":"Hoff","year":"2000","journal-title":"J. Behav. Health Serv. Res."},{"issue":"10","key":"10.1016\/j.schres.2011.04.028_bb0035","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on Quality of Life of second- vs. first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2011.04.028_bb0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/jcp.0b013e3181602cf3","article-title":"Time to discontinuation and self-discontinuation of olanzapine and risperidone in patients with schizophrenia in a naturalistic outpatient setting","volume":"28","author":"Kilzieh","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2011.04.028_bb0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2006.02.023","article-title":"Long-term combination antipsychotic treatment in VA patients with schizophrenia","volume":"84","author":"Kreyenbuhl","year":"2006","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2011.04.028_bb0050","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/schbul\/sbp046","article-title":"Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: a review of the literature","volume":"35","author":"Kreyenbuhl","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2011.04.028_bb0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/schbul\/sbp130","article-title":"The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009","volume":"36","author":"Kreyenbuhl","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.schres.2011.04.028_bb0060","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature","volume":"63","author":"Lacro","year":"2002","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2011.04.028_bb0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4088\/JCP.v69n0107","article-title":"A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia","volume":"69","author":"Law","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2011.04.028_bb0070","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.schres.2011.04.028_bb0075","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10488-007-0130-2","article-title":"Residential mobility among patients in the VA health system: associations with psychiatric morbidity, geographic accessibility, and continuity of care","volume":"34","author":"McCarthy","year":"2007","journal-title":"Adm. Policy Ment. Health"},{"issue":"Suppl 1","key":"10.1016\/j.schres.2011.04.028_bb0080","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.clinthera.2010.01.003","article-title":"Patterns of discontinuation of atypical antipsychotics in the province of Qu\u00e9bec: a retrospective prescription claims database analysis","volume":"32","author":"Moisan","year":"2010","journal-title":"Clin. Ther."},{"issue":"1\u20133","key":"10.1016\/j.schres.2011.04.028_bb0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.schres.2007.04.035","article-title":"Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia","volume":"98","author":"Mullins","year":"2008","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2011.04.028_bb0090","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ps.51.2.216","article-title":"Predicting medication noncompliance after hospital discharge among patients with schizophrenia","volume":"51","author":"Olfson","year":"2000","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.schres.2011.04.028_bb0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2710.2006.00711.x","article-title":"Treatment persistence: a comparison among patients with schizophrenia who were initiated on atypical antipsychotic agents","volume":"31","author":"Ren","year":"2006","journal-title":"J. Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.schres.2011.04.028_bb0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1176\/appi.ajp.163.4.563","article-title":"Practical treatment information for schizophrenia","volume":"163","author":"Tamminga","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2011.04.028_bb0105","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/schbul\/sbj075","article-title":"Defining and assessing adherence to oral antipsychotics: a review of the literature","volume":"32","author":"Velligan","year":"2006","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2011.04.028_bb0110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/schbul\/21.3.419","article-title":"Cost of relapse in schizophrenia","volume":"21","author":"Weiden","year":"1995","journal-title":"Schizophr. Bull."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411002350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411002350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T19:03:52Z","timestamp":1741201432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996411002350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":23,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0920996411002350"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2011.04.028","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}